Physician profile
Aziz Basem Nicholas Qandah
NPI 1528218773
$1,117,386.61
in general payments reported to CMS, 2019-2025
40 companies · $173K in 2025
The $173K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248K · 2020: $111K · 2021: $123K · 2022: $192K · 2023: $140K · 2024: $130K · 2025: $173K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $408K · Education: $14K · Consulting Fee: $13K · Food and Beverage: $7,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $407,627.05 |
| Education | $14,175.00 |
| Consulting Fee | $13,368.75 |
| Food and Beverage | $7,606.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $365,115.38 | 2019-2025 | Altera, Creo Mcs, Fenestrated, Sideloading, Creo |
| Precision Spine, INC. | $320,443.73 | 2019-2023 | |
| Orthofix Medical, INC. | $228,719.57 | 2023-2025 | Mariner Mis, Physio-Stim |
| Seaspine Orthopedics Corporation | $96,109.56 | 2019-2022 | |
| Choice Spine, LLC | $42,172.72 | 2019-2020 | |
| Baxter Healthcare | $25,874.15 | 2022-2025 | Floseal, Tisseel, Ostene |
| Xenco Medical LLC | $13,500.00 | 2019 | |
| Synergy Biomedical, LLC | $9,000.00 | 2022 | |
| The Institute of Musculoskeletal Science and Education | $7,047.19 | 2025 | Orthros, Spira |
| Boston Scientific Corporation | $3,825.41 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Elevation Spine, INC. | $1,500.00 | 2023 | |
| Intrinsic Therapeutics | $1,467.88 | 2022-2025 | Barricaid Acd (Annular Closure Device) |
| Integra Lifesciences Corporation | $403.76 | 2021-2025 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Camber Spine Technologies LLC | $366.59 | 2021-2023 | |
| Acelrx Pharmaceuticals, INC. | $331.59 | 2021-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curiteva, INC. | $257.92 | 2024-2025 | |
| Depuy Synthes Sales INC. | $197.31 | 2020-2025 | Monovisc, Orthovisc |
| Spr Therapeutics, INC | $117.26 | 2025 | Sprint Pns System |
| Smith+Nephew, INC. | $100.20 | 2024 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Oasis, Collagenase Santyl |
| Tela Bio, INC. | $88.28 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Spinal Simplicity, LLC | $78.75 | 2024 | Ha Minuteman G3-R |
| Spinal Elements, INC. | $76.77 | 2022-2023 | |
| 7d Surgical INC. | $71.19 | 2020 | |
| Brainlab, INC. | $66.20 | 2022 | |
| Ge Healthcare | $47.56 | 2020 | |
| Relievant Medsystems, INC. | $44.60 | 2021-2022 | |
| Gs Solutions, INC. | $43.90 | 2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $37.63 | 2022 | |
| Mml US, INC. | $33.38 | 2025 | Reactiv8 |
| Spine Wave, INC. | $32.05 | 2025 | Salvo Spine System |
| Sanara Medtech INC. | $30.00 | 2024 | Celleraterx |
| Lemaitre Vascular, INC. | $29.72 | 2023 | Anastoclip Gc 8cm (Medium) |
| Medtronic, INC. | $27.01 | 2025 | Synchromedii |
| Pfizer INC. | $25.23 | 2023 | |
| Abbvie INC. | $24.97 | 2023 | |
| Si-Bone, INC. | $24.92 | 2021-2022 | |
| Aesculap, INC. | $21.08 | 2024 | Elan 4 |
| Alexion Pharmaceuticals, INC. | $12.31 | 2022 | |
| Allergan, INC. | $11.75 | 2021 | |
| Centinel Spine, LLC | $9.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,113,022.94 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aziz Basem Qandah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.